IDG-Backed Shenogen Said to Interview Banks for $300 Million IPO

Bookmark
(Bloomberg) -- Shenogen Pharma Group, the Chinese cancer drug developer backed by IDG Capital, is interviewing banks for a Hong Kong initial public offering that could raise as much as $300 million...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.